Stereoscopic digital mammography, a new 3D technique, significantly improves the accuracy of breast cancer detection in high-risk women.
Stereoscopic digital mammography, a new three-dimensional technique, significantly improves the accuracy of breast cancer detection in high-risk women, according to a study published online in the journal Radiology.
Using stereoscopic digital mammography (SDM), physicians can see beyond the two-dimensional images provided by X-ray mammography, in which surrounding normal tissue can mask lesions. Modified digital mammography equipment allows the X-ray tube to move separately from the cassette and resulting images are viewed on two monitors. This provides slightly different views of the internal structure of the breast.
Researchers from Atlanta compared SDM images with 2-D digital mammograms from 779 women who were at high risk of developing breast cancer. A total of 1,298 exams were independently interpreted by two radiologists, whose findings were correlated with one-year follow-up findings or biopsy.
The findings showed that the specificity of SDM was 91.2 percent, better than the 87.8 percent rate for 2-D digital mammography. The accuracy was 90.0 percent for SDM, compared with 87.4 percent for 2-D imaging.
“We found that the stereoscopic technique could significantly decrease the need for calling back women for additional exams,” said Carl. J. D’Orsi, MD, from the Department of Radiology and Imaging Sciences at Emory University School of Medicine and the Winship Cancer Institute at Emory.
Further study is needed as the radiation dose used for this study was double the standard dose, researchers said.
“Now that we now the technique is worthwhile,” D’Orsi said, “we’re repeating the study in the general population with a dose comparable to routine screening mammography.”
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.